https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Viral Immunol. 2007;20(1):160-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Viral Immunol. 2007;20(1):160-92007-01-01 00:00:002019-02-15 09:15:11Dendritic cell-based vaccine strategy against human immunodeficiency virus clade C: skewing the immune response toward a helper T cell type 2 profile
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:387-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:387-932007-01-01 00:00:002019-02-15 09:16:56Cell technologies in immunotherapy of cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / J. Immunother. 2007 Jan;30(1):116-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / J. Immunother. 2007 Jan;30(1):116-222007-01-01 00:00:002019-02-15 09:17:01Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:381-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:381-62007-01-01 00:00:002019-02-15 09:19:41Lymphocyte subpopulations in melanoma patients treated with dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-23 / Breast Cancer Res. Treat. 2007 Nov;105(3):277-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-23 / Breast Cancer Res. Treat. 2007 Nov;105(3):277-862006-12-23 00:00:002019-02-15 08:50:18Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-19 / Biotechnol. Lett. 2007 Mar;29(3):351-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-19 / Biotechnol. Lett. 2007 Mar;29(3):351-72006-12-19 00:00:002019-02-15 09:19:44Larger numbers of immature dendritic cells augment an anti-tumor effect against established murine melanoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-15 / Nat. Rev. Immunol. 2007 Jan;7(1):19-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-15 / Nat. Rev. Immunol. 2007 Jan;7(1):19-302006-12-15 00:00:002019-02-15 08:44:39Steady-state and inflammatory dendritic-cell development
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / J Clin Apher 2006 Dec;21(4):233-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / J Clin Apher 2006 Dec;21(4):233-402006-12-01 00:00:002019-02-15 08:32:37Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Int J Hyperthermia 2006 Dec;22(8):699-712
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Int J Hyperthermia 2006 Dec;22(8):699-7122006-12-01 00:00:002019-02-15 08:35:06Artificial cytokine storm combined with hyperthermia induces significant anti-tumor effect in mice inoculated with lewis lung carcinoma and B16 melanoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Ann. Surg. 2006 Dec;244(6):986-92; discussion 992-3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Ann. Surg. 2006 Dec;244(6):986-92; discussion 992-32006-12-01 00:00:002020-06-23 09:36:05Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ
